TARS - Tarsus Pharmaceuticals, Inc.
About Tarsus Pharmaceuticals, Inc. (https://www.tarsusrx.com)
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Bobak R. Azamian | Co-Founder, President, Chief Executive Officer & Chairman | – | $1,318,208 USD |
| Jeffrey S. Farrow | Chief Financial Officer & Chief Strategy Officer | 1962 | $888,645 USD |
| Seshadri Neervannan | Chief Operating Officer | 1968 | $839,200 USD |
| Aziz Mottiwala | Chief Commercial Officer | 1978 | $821,650 USD |
| Bryan Wahl | General Counsel & Corporate Secretary | 1978 | $771,233 USD |
| Dianne C. Whitfield | Chief Human Resources Officer | 1977 | $578,900 USD |
| Elizabeth Yeu | Chief Medical Officer | 1979 | $156,691 USD |
| Adrienne Kemp | Senior Director of Corporate Communications | – | – |
| Cara Miller | Senior Vice President of Corporate Affairs | – | – |
| David Nakasone | Head of Investor Relations | – | – |
| Matthew Rossen | Vice President of Marketing | 1978 | – |
| Neera Clase | Senior Vice President of Market Access | – | – |
| Scott Youmans | Vice President of Sales | – | – |